Niu, T., Liu, L., Wu, H., Zhou, K., Yang, W., Wang, L., Cheng, S., Wang, J., Yang, J., Li, F., Zhou, S., Tong, Y., Tan, K., Liang, A. R., Yang, L., Chen, L., Zhao, W. L. (2025). High HDAC I/IIb selective inhibitor purinostat mesylate in relapsed and refractory peripheral T-cell lymphoma: A single-agent phase IIa study. Blood. https://doi.org/10.1182/blood-2025-5415